Clinical Trials Logo

Clinical Trial Summary

Observation study measuring medical response in contaminated environment.


Clinical Trial Description

This is an ongoing multicentric observational study that aims to assess the medical response to chemical events during the last five (5) decades (i.e.: 1970-2020), and in any future chemical attack that might occur within the next 15 years (i.e.: 2021-2036). Of note, the data collection will be performed retrospectively and after sites review ethic board (REB) approval. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05026645
Study type Observational
Source St. Justine's Hospital
Contact
Status Enrolling by invitation
Phase
Start date October 1, 2020
Completion date October 1, 2035

See also
  Status Clinical Trial Phase
Recruiting NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Enrolling by invitation NCT04695392 - Restore Resilience in Critically Ill Children N/A
Recruiting NCT04972318 - Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia N/A
Completed NCT04534569 - Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
Completed NCT04078984 - Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
Active, not recruiting NCT04451291 - Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure N/A
Not yet recruiting NCT04870125 - Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS) Phase 1
Not yet recruiting NCT04347967 - Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS) Phase 1
Not yet recruiting NCT05000671 - A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome Phase 1
Not yet recruiting NCT04472260 - Early Verticalization of the Patient With Acute Respiratory Distress Syndrome: Assessment of Feasibility and Safety. N/A
Not yet recruiting NCT04903262 - Ultra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS N/A
Not yet recruiting NCT04798716 - The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 Phase 1/Phase 2
Not yet recruiting NCT04291508 - Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery Phase 2
Not yet recruiting NCT04404387 - Lessening Organ Dysfunction With VITamin C in Septic ARDS Phase 3
Not yet recruiting NCT04909879 - Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome Phase 2
Terminated NCT02867228 - Noninvasive Estimation of Work of Breathing N/A
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Recruiting NCT02598648 - Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT02232841 - Electrical Impedance Imaging of Patients on Mechanical Ventilation N/A